Korean skincare regimes are known for producing hydrated glass-like skin and helping with acne, and LookFantastic has just dropped an entire range of must-have K-beauty skincare
If you’ve been on TikTok lately, you’ll have seen that Korean skincare has been exploding in popularity.
Searches for Korean skincare routines have gone up 550% since the beginning of July, and TikTok views of Korean skincare are currently at 3.5 billion views and counting, making it one of the biggest beauty trends of the year. Rather than using harsh chemicals that strip your skin of its natural moisture barrier, Korean skincare is all about hydration, leaving you with balanced, nourished and healthy skin that has a glass-like finish.
The unusual ingredient replenishes dry and damaged skin, as well as reducing the appearance of fine lines and wrinkles, and although some people have mixed feelings about the source of the miracle ingredient, it’s been lauded as one of the best products in a K-beauty routine. The HolikaHolika Good Cera Super Ceramide Foaming Wash, £18.65 here, is the perfect first step in your daily face washing routine, as it not only removes all the dirt and oils from your skin, but also regulates sebum production and balances your complexion, helping to treat everything from acne to dull skin.
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
South Korean lawmaker urges US to abandon China chip strategy\n\t\t\tKeep abreast of significant corporate, financial and political developments around the world.\n\t\t\tStay informed and spot emerging risks and opportunities with independent global reporting, expert\n\t\t\tcommentary and analysis you can trust.\n\t\t
Lire la suite »
Thousands of Scouts to Leave South Korean World Jamboree as Storm LoomsSouth Korea is preparing to evacuate tens of thousands of scouts from a coastal jamboree site as Tropical Storm Khanun looms
Lire la suite »
Kim Jong Un tells North Korean arms factories to increase production - days after Russia's defence minister visitsThe US believes North Korea is selling weapons to Russia for its invasion of Ukraine, but despite denials by Pyongyang, it has aligned itself with Moscow over the war.
Lire la suite »
Kim Jung Un Tours Arms Factories, Takes Aim at WestKim Jong Un pledged to speed up efforts to advance his military's arms and war readiness, state media said Sunday
Lire la suite »
Comparative cardiovascular outcomes in type 2 diabetes patients taking dapagliflozin versus empagliflozin: a nationwide population-based cohort study - Cardiovascular DiabetologyBackground Sodium-glucose co-transporter-2 inhibitors displayed cardiovascular benefits in type 2 diabetes mellitus in previous studies; however, there were some heterogeneities regarding respective cardiovascular outcomes within the class. Furthermore, their efficacies in Asians, females, and those with low cardiovascular risks were under-represented. Thus, we compared the cardiovascular outcomes between new users of dapagliflozin and empagliflozin in a broad range of patients with type 2 diabetes mellitus using a nationwide population-based real-world cohort from Korea. Methods Korean National Health Insurance registry data between May 2016 and December 2018 were extracted, and an active-comparator new-user design was applied. The primary outcome was a composite of heart failure (HF)-related events (i.e., hospitalization for HF and HF-related death), myocardial infarction, ischemic stroke, and cardiovascular death. The secondary outcomes were individual components of the primary outcome. Results A total of 366,031 new users of dapagliflozin or empagliflozin were identified. After 1:1 nearest-neighbor propensity score matching, 72,752 individuals (mean age approximately 56 years, 42% women) from each group were included in the final analysis, with a follow-up of 150,000 ~ person-years. Approximately 40% of the patients included in the study had type 2 diabetes mellitus as their sole cardiovascular risk factor, with no other risk factors. The risk of the primary outcome was not different significantly between dapagliflozin and empagliflozin users (hazard ratio [HR] 0.93, 95% confidence interval [CI] 0.855–1.006). The risks of secondary outcomes were also similar, with the exception of the risks of HF-related events (HR 0.84, 95% CI 0.714–0.989) and cardiovascular death (HR 0.76, 95% CI 0.618–0.921), which were significantly lower in the dapagliflozin users. Conclusions This large-scale nationwide population-based real-world cohort study revealed no significant diffe
Lire la suite »
Michael Mosley shares healthy snacks he 'always' keeps in stock to eat every dayMichael Mosley reveals healthy snacks he 'always' keeps in stock to eat every day
Lire la suite »